Patient Safety Technologies Reports Second Quart...(Liabilities and Stockholders' ...),Health

Date:8/6/2009

Liabilities and Stockholders' (Deficit) Equity Current liabilities Accounts payable $1,770 $909 Current portion of convertible debentures 1,425 1,425 Current portion of notes payable 600 1,100 Accrued liabilities 9,983 3,358 ----- ----- Total current liabilities 13,778 6,792 Long-term convertible debentures, less current portion 53 51 Long-term notes payable, less current portion 1,530 - Deferred tax liabilities 979 1,042 --- ----- Total liabilities 16,340 7,885 ------ ----- Stockholders' equity: Convertible preferred stock, $1.00 par value, cumulative 7% dividend: 1,000 shares authorized; 11 issued and outstanding at June 30, 2009 and December 31, 2008: (Liquidation preference of $1.2 million at June 30, 2009 and December 31, 2008 11 11 Common stock, $0.33 par value: 25,000 shares authorized; 17,198 shares issued and outstanding at June 30, 2009 and December 31, 2008; 5,675 5,675 Additional paid-in capital 35,767 36,034 Accumulated deficit (49,985) (41,691) ------- ------- Total stockholders' (deficit) equity (8,532) 29
'/>"/>

SOURCE Patient Safety Technologies, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7
Related medicine news :

1. California Cancer Specialists Medical Group, Inc. Opens Outpatient Cancer Center in South Pasadena, Calif., With Renowned Medical Staff, State-of-the-Art Technology
2. Kool Smiles Relies on Wyse Technology Virtual Clients to Improve Patient Care and Security of Electronic Health Records (EHRs)
3. Inpatient Management, Inc. and Reid Hospital Achieve Performance Improvement and Cost Savings
4. Bellicum Pharmaceuticals Announces Initiation of Phase I/II Clinical Trial of Novel Vaccine for Patients With Advanced Prostate Cancer
5. Genome of Leukemia Patient Reveals Common Mutations
6. Digital mammography plus digital breast tomosynthesis may decrease patient recall rates
7. Happy Employees Lead to Healthier Patients
8. Londons Barts Hospital Selects Varian Equipment to Offer Advanced Radiotherapy to More Cancer Patients
9. Lilly Broadens Income Eligibility for Patient Assistance Programs
10. Surveyed Physicians Will Treat Over 50 Percent of Hepatitis C Genotype 1-Infected Patients With the Protease Inhibitor Telaprevir
11. Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis